Pulse Biosciences Valuation
| PLSE Stock | USD 19.63 1.84 10.34% |
At this time, the company appears to be overvalued. Pulse Biosciences holds a recent Real Value of $11.95 per share. The prevailing price of the company is $19.63. Our model determines the value of Pulse Biosciences from analyzing the company fundamentals such as Return On Equity of -0.7, shares owned by institutions of 9.31 %, and Shares Outstanding of 61.52 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Pulse Biosciences' valuation include:
Price Book 15.2604 | Enterprise Value | Enterprise Value Ebitda (1.81) | Price Sales 60.229 | Enterprise Value Revenue 64.6261 |
Overvalued
Today
Please note that Pulse Biosciences' price fluctuation is moderately volatile at this time. Calculation of the real value of Pulse Biosciences is based on 3 months time horizon. Increasing Pulse Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Pulse stock is determined by what a typical buyer is willing to pay for full or partial control of Pulse Biosciences. Since Pulse Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pulse Stock. However, Pulse Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.63 | Real 11.95 | Target 5.0 | Hype 19.99 |
The real value of Pulse Stock, also known as its intrinsic value, is the underlying worth of Pulse Biosciences Company, which is reflected in its stock price. It is based on Pulse Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Pulse Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Pulse Biosciences helps investors to forecast how Pulse stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pulse Biosciences more accurately as focusing exclusively on Pulse Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Pulse Biosciences' intrinsic value based on its ongoing forecasts of Pulse Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Pulse Biosciences' closest peers. If more than one evaluation category is relevant for Pulse Biosciences we suggest using both methods to arrive at a better estimate.
Pulse Biosciences Cash |
|
Pulse Valuation Trend
Comparing Pulse Biosciences' enterprise value against its market capitalization is a good way to estimate the value of Pulse Biosciences uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Pulse Biosciences Total Value Analysis
Pulse Biosciences is at this time projected to have valuation of 1.02 B with market capitalization of 992.88 M, debt of 9.14 M, and cash on hands of 14.8 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Pulse Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.02 B | 992.88 M | 9.14 M | 14.8 M |
Pulse Biosciences Investor Information
About 72.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.82. Pulse Biosciences had not issued any dividends in recent years. Based on the key indicators related to Pulse Biosciences' liquidity, profitability, solvency, and operating efficiency, Pulse Biosciences may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Pulse Biosciences Asset Utilization
One of the ways to look at asset utilization of Pulse is to check how much profit was generated for every dollar of assets it reports. Pulse Biosciences holds a negative application of assets of -0.38 pct., losing $0.003815 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Pulse Biosciences shows how discouraging it operates for each dollar spent on its assets.Pulse Biosciences Ownership Allocation
Pulse Biosciences owns a total of 61.52 Million outstanding shares. Pulse Biosciences holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 71.93 pct. of Pulse Biosciences outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Pulse Biosciences Profitability Analysis
Net Loss for the year was (42.21 M) with loss before overhead, payroll, taxes, and interest of (550 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Pulse Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Pulse Biosciences and how it compares across the competition.
About Pulse Biosciences Valuation
The stock valuation mechanism determines Pulse Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Pulse Biosciences. We calculate exposure to Pulse Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pulse Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -1.1 M | -1.1 M | |
| Pretax Profit Margin | (96.12) | (100.92) | |
| Operating Profit Margin | (95.38) | (100.15) | |
| Net Loss | (96.85) | (101.69) | |
| Gross Profit Margin | (18.47) | (17.55) |
Pulse Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Pulse Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 48 M |
Pulse Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Pulse Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Pulse we look at many different elements of the entity such as Pulse's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Pulse Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Pulse Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Pulse Biosciences' worth.Complementary Tools for Pulse Stock analysis
When running Pulse Biosciences' price analysis, check to measure Pulse Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulse Biosciences is operating at the current time. Most of Pulse Biosciences' value examination focuses on studying past and present price action to predict the probability of Pulse Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulse Biosciences' price. Additionally, you may evaluate how the addition of Pulse Biosciences to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |